2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia HRS-7249 Injection, Sodium Chloride Injection - Hyperlipidemia | Phase 2 | Active not recruiting | Fujian Shengdi Pharmaceutical Co., Ltd. | 224 | 2025-08-12 | 2026-06-03 |
| Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy Metreleptin - Diabetes, Lipodystrophy | Phase 2 | Active not recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 29 | 2014-10-14 | 2026-11-09 |
Hyperlipidemias (2) · Diabetes Mellitus (1) · Hypertriglyceridemia (1) · Lipodystrophy (1)
Dyslipidemias (2) · Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Skin Diseases (1) · Skin Diseases, Metabolic (1) · Skin and Connective Tissue Diseases (1)
Sodium Chloride (1) · metreleptin (1)
Fujian Shengdi Pharmaceutical Co., Ltd. (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
China (1) · United States (1)